146 related articles for article (PubMed ID: 37987107)
21. Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma.
Handa T; Hayashi T; Ura A; Watanabe I; Takamochi K; Onagi H; Kishi M; Matsumoto N; Tajima K; Kishikawa S; Saito T; Takahashi K; Suzuki K; Yao T
Histopathology; 2023 May; 82(6):860-869. PubMed ID: 36715573
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer.
Zheng Y; Wang Z; Wei S; Liu Z; Chen G
Cancer Lett; 2021 Feb; 499():148-163. PubMed ID: 33253790
[TBL] [Abstract][Full Text] [Related]
23. Association of GWAS-identified lung cancer susceptibility loci with survival length in patients with small-cell lung cancer treated with platinum-based chemotherapy.
Li D; Wei L; Xu B; Yu D; Chang J; Yuan P; Du Z; Tan W; Shen H; Wu T; Wu C; Lin D
PLoS One; 2014; 9(11):e113574. PubMed ID: 25415319
[TBL] [Abstract][Full Text] [Related]
24. Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis.
Yoo SS; Lee JH; Hong MJ; Choi JE; Kang HG; Do SK; Kim JH; Baek SA; Choi SH; Lee WK; Lee YH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Thorac Cancer; 2020 Sep; 11(9):2698-2703. PubMed ID: 32700476
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients.
Dai Y; Zhang L; Hu C; Zhang Y
Clin Exp Rheumatol; 2010; 28(2):158-68. PubMed ID: 20483040
[TBL] [Abstract][Full Text] [Related]
26. Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.
Hokari S; Tamura Y; Kaneda A; Katsura A; Morikawa M; Murai F; Ehata S; Tsutsumi S; Ishikawa Y; Aburatani H; Kikuchi T; Miyazono K; Koinuma D
Mol Oncol; 2020 Feb; 14(2):277-293. PubMed ID: 31782890
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of the TGFβ1 rs4803455 single nucleotide polymorphism in small cell lung cancer.
Ayala de Miguel P; Enguix-Riego MV; Cacicedo J; Delgado BD; Perez M; Praena-Fernández JM; Quintana Cortés L; Borrega García P; Del Campo ER; Lopez Guerra JL
Tumori; 2021 Jun; 107(3):209-215. PubMed ID: 32779517
[TBL] [Abstract][Full Text] [Related]
28. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
Niu N; Schaid DJ; Abo RP; Kalari K; Fridley BL; Feng Q; Jenkins G; Batzler A; Brisbin AG; Cunningham JM; Li L; Sun Z; Yang P; Wang L
BMC Cancer; 2012 Sep; 12():422. PubMed ID: 23006423
[TBL] [Abstract][Full Text] [Related]
29. Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma.
Kang HG; Lee YH; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Sci Rep; 2021 Nov; 11(1):21520. PubMed ID: 34728688
[TBL] [Abstract][Full Text] [Related]
30. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.
Kalari S; Jung M; Kernstine KH; Takahashi T; Pfeifer GP
Oncogene; 2013 Jul; 32(30):3559-68. PubMed ID: 22907430
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in the apoptotic pathway gene BCL-2 and survival in small cell lung cancer.
Knoefel LF; Werle-Schneider G; Dally H; Müller PJ; Edler L; Bartsch H; Tuengerthal S; Heussel CP; Reinmuth N; Thomas M; Risch A
J Thorac Oncol; 2011 Jan; 6(1):183-9. PubMed ID: 21107291
[TBL] [Abstract][Full Text] [Related]
32. Genetic Polymorphisms in Activating Transcription Factor 3 Binding Site and the Prognosis of Early-Stage Non-Small Cell Lung Cancer.
Kang HG; Park JE; Lee SY; Choi JE; Do SK; Hong MJ; Lee JH; Jeong JY; Do YW; Lee EB; Shin KM; Lee WK; Choi SH; Lee YH; Seo HW; Yoo SS; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
Oncology; 2021; 99(5):336-344. PubMed ID: 33626541
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study.
Farjadfar A; Mojtahedi Z; Ghayumi MA; Erfani N; Haghshenas MR; Ghaderi A
Acta Oncol; 2009; 48(7):971-6. PubMed ID: 19642044
[TBL] [Abstract][Full Text] [Related]
34. Distinct features of H3K4me3 and H3K27me3 chromatin domains in pre-implantation embryos.
Liu X; Wang C; Liu W; Li J; Li C; Kou X; Chen J; Zhao Y; Gao H; Wang H; Zhang Y; Gao Y; Gao S
Nature; 2016 Sep; 537(7621):558-562. PubMed ID: 27626379
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of ChIP-seq data uncovers dynamic and sustained H3K4me3 and H3K27me3 modulation in cancer cells under hypoxia.
Adriaens ME; Prickaerts P; Chan-Seng-Yue M; van den Beucken T; Dahlmans VEH; Eijssen LM; Beck T; Wouters BG; Voncken JW; Evelo CTA
Epigenetics Chromatin; 2016; 9():48. PubMed ID: 27822313
[TBL] [Abstract][Full Text] [Related]
36. Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome.
Lee JH; Yoo SS; Hong MJ; Choi JE; Kim S; Kang HG; Do SK; Kim JH; Baek SA; Lee WK; Do Yoo J; Choi SH; Lee YH; Seo H; Lee J; Lee SY; Cha SI; Kim CH; Park JY
Sci Rep; 2021 Jan; 11(1):1794. PubMed ID: 33469055
[TBL] [Abstract][Full Text] [Related]
37. Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.
Geng N; Ding CM; Liu ZK; Song S; Hu WX
Int J Clin Oncol; 2021 Apr; 26(4):670-683. PubMed ID: 33392882
[TBL] [Abstract][Full Text] [Related]
38. Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor-based subtype assignment in paired tumour samples from small cell lung carcinoma.
Denize T; Meador CB; Rider AB; Ganci ML; Barth JL; Kem M; Mino-Kenudson M; Hung YP
Histopathology; 2023 Dec; 83(6):912-924. PubMed ID: 37644667
[TBL] [Abstract][Full Text] [Related]
39. Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
Allison Stewart C; Tong P; Cardnell RJ; Sen T; Li L; Gay CM; Masrorpour F; Fan Y; Bara RO; Feng Y; Ru Y; Fujimoto J; Kundu ST; Post LE; Yu K; Shen Y; Glisson BS; Wistuba I; Heymach JV; Gibbons DL; Wang J; Byers LA
Oncotarget; 2017 Apr; 8(17):28575-28587. PubMed ID: 28212573
[TBL] [Abstract][Full Text] [Related]
40. A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
Han JY; Lee YS; Shin ES; Hwang JA; Nam S; Hong SH; Ghang HY; Kim JY; Yoon SJ; Lee JS
Pharmacogenomics J; 2014 Feb; 14(1):20-7. PubMed ID: 23478653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
